Ruotsalainen UH - Search Results

1

PET studies on brain monoamine transporters with carbon-11-beta-CIT in Parkinson's disease.

Laihinen AO, Rinne JO, Någren KA, Lehikoinen PK, Oikonen VJ, Ruotsalainen UH, Ruottinen HM, Rinne UK. Laihinen AO, et al. Among authors: ruotsalainen uh. J Nucl Med. 1995 Jul;36(7):1263-7. J Nucl Med. 1995. PMID: 7790953 Free article.

2

PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756.

Laihinen AO, Rinne JO, Ruottinen HM, Någren KA, Lehikoinen PK, Oikonen VJ, Ruotsalainen UH, Rinne UK. Laihinen AO, et al. Among authors: ruotsalainen uh. J Nucl Med. 1994 Dec;35(12):1916-20. J Nucl Med. 1994. PMID: 7989969 Free article. Clinical Trial.

3

Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.

Ruottinen HM, Rinne JO, Oikonen VJ, Bergman JR, Haaparanta MT, Solin OH, Ruotsalainen UH, Rinne UK. Ruottinen HM, et al. Among authors: ruotsalainen uh. Synapse. 1997 Dec;27(4):336-46. doi: 10.1002/(SICI)1098-2396(199712)27:4<336::AID-SYN7>3.0.CO;2-D. Synapse. 1997. PMID: 9372556

4

Striatal [18F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease.

Ruottinen HM, Rinne JO, Ruotsalainen UH, Bergman JR, Oikonen VJ, Haaparanta MT, Solin OH, Laihinen AO, Rinne UK. Ruottinen HM, et al. Among authors: ruotsalainen uh. J Neural Transm Park Dis Dement Sect. 1995;10(2-3):91-106. doi: 10.1007/BF02251225. J Neural Transm Park Dis Dement Sect. 1995. PMID: 9620057 Clinical Trial.

5

Carbon-11-methionine and PET is an effective method to image head and neck cancer.

Leskinen-Kallio S, Någren K, Lehikoinen P, Ruotsalainen U, Teräs M, Joensuu H. Leskinen-Kallio S, et al. J Nucl Med. 1992 May;33(5):691-5. J Nucl Med. 1992. PMID: 1569477 Free article.

6

[11C]methionine quantitation in cancer PET studies.

Leskinen-Kallio S, Huovinen R, Någren K, Lehikoinen P, Ruotsalainen U, Teräs M, Joensuu H. Leskinen-Kallio S, et al. J Comput Assist Tomogr. 1992 May-Jun;16(3):468-74. doi: 10.1097/00004728-199205000-00023. J Comput Assist Tomogr. 1992. PMID: 1592933

7

Positron emission tomography of brain dopamine D-2 receptors with 11C-raclopride in early Parkinson's disease.

Laihinen A, Rinne JO, Någren K, Bergman J, Haaparanta M, Solin O, Ruotsalainen U, Rinne UK. Laihinen A, et al. Acta Radiol Suppl. 1991;376:151. Acta Radiol Suppl. 1991. PMID: 1666759 No abstract available.

8

Positron emission tomography of brain dopamine D-1 receptors with 11C-SCH 23390 in Parkinson's disease.

Rinne JO, Laihinen A, Någren K, Bergman J, Haaparanta M, Solin O, Ruotsalainen U, Rinne UK. Rinne JO, et al. Acta Radiol Suppl. 1991;376:152. Acta Radiol Suppl. 1991. PMID: 1666760 No abstract available.

9

[18F]-6-fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR-462).

Laihinen A, Rinne JO, Rinne UK, Haaparanta M, Ruotsalainen U, Bergman J, Solin O. Laihinen A, et al. Neurology. 1992 Jan;42(1):199-203. doi: 10.1212/wnl.42.1.199. Neurology. 1992. PMID: 1734304

10

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease.

Rinne JO, Laihinen A, Någren K, Bergman J, Solin O, Haaparanta M, Ruotsalainen U, Rinne UK. Rinne JO, et al. J Neurosci Res. 1990 Dec;27(4):494-9. doi: 10.1002/jnr.490270409. J Neurosci Res. 1990. PMID: 1981915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters